Apotex Corp. recalls Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canad
Recalled April 14, 2021 · FDA recall D-0324-2021 · Apotex
Hazard
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate · FDA Class II
Units
55620 bottles
Sold at
Nationwide within the United States
Description
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
Product
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-3928-1, UPC 3 60505 39281 0
Manufacturer(s)
Apotex Corp.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →